Diabetes mellitus is not associated with worse vascular outcome following percutaneous transfemoral transcatheter aortic valve implantation

[1]  J. Raffort,et al.  A 7-Year Single-Center Experience of Transfemoral TAVI: Evolution of Surgical Activity and Impact on Vascular Outcome , 2018, Angiology.

[2]  J. Raffort,et al.  Surgical Management of Percutaneous Transfemoral Access to Minimize Vascular Complications Related to Transcatheter Aortic Valve‘ Implantation , 2018, Angiology.

[3]  N. Lorenzo-Villalba,et al.  Transcatheter aortic valve implantation and surgical aortic valve replacement among hospitalized patients with and without type 2 diabetes mellitus in Spain (2014–2015) , 2017, Cardiovascular Diabetology.

[4]  T. Ando,et al.  Does diabetes mellitus impact prognosis after transcatheter aortic valve implantation? Insights from a meta-analysis. , 2017, Journal of cardiology.

[5]  J. Raffort,et al.  Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation , 2017, Vascular and endovascular surgery.

[6]  R. Makkar,et al.  Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Implantation. , 2016, The American journal of cardiology.

[7]  A. Steinvil,et al.  Impact of Diabetes Mellitus and Hemoglobin A1C on Outcome After Transcatheter Aortic Valve Implantation. , 2015, The American journal of cardiology.

[8]  I. Barbash,et al.  Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement , 2015, Cardiovascular Diabetology.

[9]  M. Mack,et al.  A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis. , 2015, Journal of the American College of Cardiology.

[10]  G. Hasenfuss,et al.  [Diabetes increases short- and long-term mortality after transcatheter aortic valve implantation (TAVI)]. , 2014, Deutsche medizinische Wochenschrift.

[11]  F. Gaita,et al.  Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry). , 2014, The American journal of cardiology.

[12]  Shannon D. Thomas,et al.  Incidence and prognosis of vascular complications after transcatheter aortic valve implantation. , 2013, Journal of vascular surgery.

[13]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[14]  J. Bavaria,et al.  Clinical ResearchInterventional CardiologyVascular Complications After Transcatheter Aortic Valve Replacement: Insights From the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial , 2012 .

[15]  Susheel Kodali,et al.  Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. , 2012, Journal of the American College of Cardiology.

[16]  M. Morice,et al.  True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. , 2012, JACC. Cardiovascular interventions.

[17]  P. Jüni,et al.  Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. , 2011, American heart journal.

[18]  D. Wood,et al.  Transcatheter aortic valve implantation , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  R. Guyton,et al.  The effect of diabetes mellitus on in-hospital and long-term outcomes after heart valve operations. , 2010, The Annals of thoracic surgery.

[20]  Fabian Nietlispach,et al.  Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.

[21]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.